South Korea Neurology Devices Market: Market Size & Forecast 2026

South Korea's neurology devices market covers a broad range of products including neurovascular, neurostimulation, neurosurgery, and diagnostic imaging equipment for treating conditions such as stroke, aneurysms, epilepsy, and traumatic brain injuries. The market is supported by one of Asia's most advanced healthcare systems, characterized by high hospital density, widespread insurance coverage, and strong clinical adoption of new technologies. While independent market analyses estimate the 2025 market size between approximately $593 million and $1.37 billion depending on methodology and scope, no official government-published market sizing figures have been publicly released by South Korean health agencies.

• •Market valued at approximately $0.981 billion in 2025 with a projected CAGR of 6.83% through 2035
• •Includes neurovascular, neurostimulation, neurosurgery, and diagnostic imaging device segments
• •No official government-published market size figures are publicly available from South Korean health agencies

South Korea's rapidly aging population is a primary catalyst, as neurological disorders such as stroke, dementia, and Parkinson's disease increase significantly with age. The country's universal healthcare system and high per-capita health spending create a favorable reimbursement environment for advanced neurology devices. Proactive government initiatives promoting medical technology innovation, combined with a robust clinical research ecosystem and one of the world's highest rates of MRI and CT scanning per capita, further accelerate adoption.

• •Aging population driving increased incidence of stroke, dementia, and neurodegenerative diseases
• •Proactive government stance supporting healthcare innovation and medical technology development
• •High healthcare infrastructure density and strong clinical research ecosystem supporting rapid device adoption

Within the South Korean market, the neurovascular devices segment, covering neurothrombectomy devices, stents, coils, and flow diverters, is a prominent sub-market driven by the high incidence of ischemic stroke. The neurothrombectomy devices sub-segment alone is projected to reach approximately $22.1 million by 2030 at a 6.2% CAGR. Neurostimulation devices for epilepsy and chronic pain management, as well as neurosurgery equipment, represent additional key segments benefiting from technological advancements and growing clinical familiarity.

• •Neurovascular devices segment growing at approximately 5.9% CAGR, driven by stroke treatment demand
• •Neurothrombectomy devices sub-segment projected at $22.1 million by 2030 at 6.2% CAGR
• •Neurostimulation and neurosurgery equipment segments expanding alongside minimally invasive technique adoption

What are the recent trends and outlook?

The market is trending toward minimally invasive and image-guided neurosurgical procedures, with rising adoption of robotic-assisted surgery and advanced thrombectomy technologies for acute stroke treatment. Digital health integration, including AI-assisted diagnostic imaging and remote neurological monitoring, is expected to create new product categories over the forecast period. Regulatory streamlining by South Korea's Ministry of Food and Drug Safety to accelerate approvals for innovative medical devices is likely to further boost market dynamism and attract global manufacturers seeking a foothold in the Asia Pacific region.

• •Minimally invasive procedures, robotic-assisted neurosurgery, and AI-assisted diagnostics are key emerging trends
• •Regulatory streamlining by South Korea's MFDS is accelerating approval timelines for innovative devices
• •Asia Pacific positioned as the fastest-growing region globally for neurology devices, with South Korea as a key market